Neurovascular complications following carotid body paraganglioma resection.

[1]  D. Deschler,et al.  Malignant head and neck paragangliomas: treatment efficacy and prognostic indicators. , 2013, American journal of otolaryngology.

[2]  T. Cohnert,et al.  Paraganglioma of the carotid body: treatment strategy and SDH-gene mutations. , 2013, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[3]  J. Thariat,et al.  Treatment of cervical paragangliomas. , 2012, European annals of otorhinolaryngology, head and neck diseases.

[4]  O. Dekkers,et al.  Risk of malignant paraganglioma in SDHB-mutation and SDHD-mutation carriers: a systematic review and meta-analysis , 2012, Journal of Medical Genetics.

[5]  W. Young,et al.  Impact of preoperative embolization on outcomes of carotid body tumor resections. , 2012, Journal of vascular surgery.

[6]  T. Yamakawa,et al.  Perioperative approach in the surgical management of carotid body tumors. , 2012, Annals of vascular surgery.

[7]  C. Boedeker.  Paragangliomas and paraganglioma syndromes , 2012, GMS current topics in otorhinolaryngology, head and neck surgery.

[8]  P. Walker,et al.  Important observations made managing carotid body tumors during a 25-year experience. , 2010, Journal of vascular surgery.

[9]  Albeir Y. Mousa,et al.  Carotid Body Tumor Surgery: Management and Outcomes in the Nation , 2009, Vascular and endovascular surgery.

[10]  S. Arya,et al.  Carotid Body Tumors: Objective Criteria to Predict the Shamblin Group on MR Imaging , 2008, American Journal of Neuroradiology.

[11]  A. Bonafe,et al.  Surgical Management of Carotid Body Tumors , 2008, Annals of Surgical Oncology.

[12]  M. Sajid,et al.  A multicenter review of carotid body tumour management. , 2007, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[13]  K. Luna-Ortiz,et al.  Does Shamblin’s classification predict postoperative morbidity in carotid body tumors? A proposal to modify Shamblin’s classification , 2006, European Archives of Oto-Rhino-Laryngology and Head & Neck.

[14]  R. Berg.  Imaging and management of head and neck paragangliomas , 2005, European Radiology.

[15]  C. Eng,et al.  Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. , 2004, JAMA.

[16]  G. Barnett,et al.  Recurrent head-and-neck chemodectomas: a comparison of surgical and radiotherapeutic results. , 2002, International journal of radiation oncology, biology, physics.

[17]  L. Karnell,et al.  National Cancer Data Base report on malignant paragangliomas of the head and neck , 2002, Cancer.

[18]  L. Reilly,et al.  Preoperative embolization of carotid body tumors: When is it appropriate? , 1996, Annals of vascular surgery.

[19]  W. R. Nelson,et al.  Carotid body tumor. , 1992, Archives of surgery.

[20]  P. Pairolero,et al.  Trends in neurovascular complications of surgical management for carotid body and cervical paragangliomas: a fifty-year experience with 153 tumors. , 1988, Journal of vascular surgery.

[21]  S. Sheps,et al.  Carotid body tumor (chemodectoma). Clinicopathologic analysis of ninety cases. , 1971, American journal of surgery.

[22]  V. Grégoire,et al.  Carotid body paragangliomas: a systematic study on management with surgery and radiotherapy , 2013, European Archives of Oto-Rhino-Laryngology.

[23]  M. Granados-García,et al.  Carotid body tumors: review of a 20-year experience. , 2005, Oral oncology.

[24]  E. Choi,et al.  Original Article Surgical Treatment of Carotid Body Paragangliomas: Outcomes and Complications According to the , 2022 .